Health Canada has issued a recall for more than 700 bottles of mislabelled cannabis oil gel capsules in New Brunswick.

“Namaste CBD Light gelcaps” from LP Zenabis actually contained THC (aka tetrahydrocannabinol) instead of CBD (cannabidiol). While both THC and CBD are psychoactive, only THC is intoxicating.

“These units contain the incorrect cannabis product,” notes the recall notice. “The label indicates that the product is ‘CBD Light gelcaps’. However, the units contain THC gelcaps.”

The recall was issued December 17.

The federal regulator reports the misidentified bottles’ labels note the capsules contain 6.13 mg of CBD and 0.19 mg of THC. The capsules actually contained 2.247 mg of THC and no CBD. Only one lot is thought to have been affected.

The recalled lot was sold to Cannabis NB this past Oct. 7, and 768 units of recalled product have been sold. Health Canada reported that it has not received any complaints or heard of any incidents relating to the recalls, although the producer has fielded one so far.

Neither Zenabis nor the regulator have received any reports of adverse reactions or issues related to the mislabelled capsules.

Zenabis had another product recall this year — this one voluntary — after a batch of Wappa dried flower was mislabelled as containing 6.57 percent THC and 12.1 percent CBD, when, in fact, it contained a much more potent 17.3 percent THC and just 0.07 percent CBD. This batch was sold through the Société québecoise du cannabis.

Health Canada reports that if consumers find they have purchased a bottle from the recalled lot, they may return it to the point of sale. For additional information, consumers can contact Cannabis NB directly by calling 1-833-821-2195.